OpenVSafe by OpenVAERS
Search V-safe

ZHS-19142-72016

4 vaccinations 1 coded response 17 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
946 / CA
Registered
2021-04-10
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-10
    Registered in v-safe
  2. 2021-04-10
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-10
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2021-04-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-17
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-03
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in
  12. 2021-05-10
    Health check-in — day 28, single dose
    Feeling: Good
    Adult check-in
  13. 2021-05-15
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in
  14. 2021-05-22
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  15. 2021-07-10
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  16. 2021-10-09
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  17. 2021-10-27
    Dose 2 — Pfizer-BioNTech
  18. 2022-04-10
    Survey response — 12 months, dose 1
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school
    Free text: Runny nose and congestion
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-04-22
    Dose 3 — Pfizer-BioNTech
  20. 2022-09-30
    Dose 4 — Pfizer-BioNTech
  21. 2022-10-09
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  22. 2022-11-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Janssen/Johnson & Johnson
22021-10-27Pfizer-BioNTech No
32022-04-22Pfizer-BioNTech No
42022-09-30Pfizer-BioNTech No

Free text

Release 11 — 12 months, dose 1

2022-04-10

Symptoms: Runny nose and congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…